Literature DB >> 18787880

Early Parkinson's disease and non-motor issues.

K Ray Chaudhuri1, Yogini Naidu.   

Abstract

Non motor symptoms (NMS) of PD are a key determinant of health, quality of life and societal cost of PD. Contrary to common perception, many NMS of PD occur early in PD and some may even predate the diagnosis of PD which is based on motor signs. These include olfactory deficit, sleep problems such as REM behaviour disorder, contipation and the more recently described male erectile dysfunction. The non motor quesionnaire (NMSQuest) and the recently validated NMS scale allow falgging and quantification of NMS of PD and therefore are important tools to comprehensively assess symptom load in PD.

Entities:  

Mesh:

Year:  2008        PMID: 18787880     DOI: 10.1007/s00415-008-5006-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  51 in total

1.  Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson disease.

Authors:  Michael S Okun; Benjamin L Walter; William M McDonald; Joyce L Tenover; Joanne Green; Jorge L Juncos; Mahlon R DeLong
Journal:  Arch Neurol       Date:  2002-11

2.  Increased risk of Parkinson's disease after depression: a retrospective cohort study.

Authors:  A G Schuurman; M van den Akker; K T J L Ensinck; J F M Metsemakers; J A Knottnerus; A F G Leentjens; F Buntinx
Journal:  Neurology       Date:  2002-05-28       Impact factor: 9.910

3.  Cardiac sympathetic denervation in Parkinson disease.

Authors:  D S Goldstein; C Holmes; S T Li; S Bruce; L V Metman; R O Cannon
Journal:  Ann Intern Med       Date:  2000-09-05       Impact factor: 25.391

4.  What contributes to quality of life in patients with Parkinson's disease?

Authors:  A Schrag; M Jahanshahi; N Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

5.  Nonmotor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study.

Authors:  Sean S O'Sullivan; David R Williams; David A Gallagher; Luke A Massey; Laura Silveira-Moriyama; Andrew J Lees
Journal:  Mov Disord       Date:  2008-01       Impact factor: 10.338

6.  Erectile function and risk of Parkinson's disease.

Authors:  Xiang Gao; Honglei Chen; Michael A Schwarzschild; Dale B Glasser; Giancarlo Logroscino; Eric B Rimm; Alberto Ascherio
Journal:  Am J Epidemiol       Date:  2007-09-17       Impact factor: 4.897

7.  Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease.

Authors:  R L Doty; M B Stern; C Pfeiffer; S M Gollomp; H I Hurtig
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-02       Impact factor: 10.154

8.  Assessment of idiopathic rapid-eye-movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP-CIT-SPECT.

Authors:  Marcus M Unger; Jens C Möller; Karin Stiasny-Kolster; Katharina Mankel; Daniela Berg; Uwe Walter; Helmut Hoeffken; Geert Mayer; Wolfgang H Oertel
Journal:  Mov Disord       Date:  2008-03-15       Impact factor: 10.338

Review 9.  Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease.

Authors:  David J Burn
Journal:  Mov Disord       Date:  2002-05       Impact factor: 10.338

10.  Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.

Authors:  K Stiasny-Kolster; Y Doerr; J C Möller; H Höffken; T M Behr; W H Oertel; G Mayer
Journal:  Brain       Date:  2004-11-17       Impact factor: 13.501

View more
  31 in total

1.  Sleep in essential tremor: a comparison with normal controls and Parkinson's disease patients.

Authors:  Marina Gerbin; Amanda S Viner; Elan D Louis
Journal:  Parkinsonism Relat Disord       Date:  2011-11-30       Impact factor: 4.891

Review 2.  Biochemical premotor biomarkers for Parkinson's disease.

Authors:  Brit Mollenhauer; Jing Zhang
Journal:  Mov Disord       Date:  2012-04-15       Impact factor: 10.338

3.  Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients.

Authors:  Roberto Erro; Gabriella Santangelo; Marina Picillo; Carmine Vitale; Marianna Amboni; Katia Longo; Angela Costagliola; Maria Teresa Pellecchia; Roberto Allocca; Anna De Rosa; Giuseppe De Michele; Lucio Santoro; Paolo Barone
Journal:  J Neurol       Date:  2012-02-07       Impact factor: 4.849

4.  Clinical heterogeneity in patients with early-stage Parkinson's disease: a cluster analysis.

Authors:  Ping Liu; Tao Feng; Yong-jun Wang; Xuan Zhang; Biao Chen
Journal:  J Zhejiang Univ Sci B       Date:  2011-09       Impact factor: 3.066

5.  Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort.

Authors:  E Y Uc; M P McDermott; K S Marder; S W Anderson; I Litvan; P G Como; P Auinger; K L Chou; J C Growdon
Journal:  Neurology       Date:  2009-11-03       Impact factor: 9.910

Review 6.  Progression of motor symptoms in Parkinson's disease.

Authors:  Ruiping Xia; Zhi-Hong Mao
Journal:  Neurosci Bull       Date:  2012-02       Impact factor: 5.203

Review 7.  INPH and Parkinson disease: differentiation by levodopa response.

Authors:  Takashi Morishita; Kelly D Foote; Michael S Okun
Journal:  Nat Rev Neurol       Date:  2010-01       Impact factor: 42.937

Review 8.  Innate inflammation in Parkinson's disease.

Authors:  V Hugh Perry
Journal:  Cold Spring Harb Perspect Med       Date:  2012-09-01       Impact factor: 6.915

Review 9.  Hyposmia: a possible biomarker of Parkinson's disease.

Authors:  Qian Xiao; Sheng Chen; Weidong Le
Journal:  Neurosci Bull       Date:  2013-10-17       Impact factor: 5.203

10.  Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease.

Authors:  Stephen G Brickley; Istvan Mody
Journal:  Neuron       Date:  2012-01-12       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.